147 related articles for article (PubMed ID: 28743497)
1. Molecular interaction between K-Ras and H-REV107 in the Ras signaling pathway.
Han CW; Jeong MS; Jang SB
Biochem Biophys Res Commun; 2017 Sep; 491(2):257-264. PubMed ID: 28743497
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional characterization of tumor suppressors TIG3 and H-REV107.
Wei H; Wang L; Ren X; Yu W; Lin J; Jin C; Xia B
FEBS Lett; 2015 May; 589(11):1179-86. PubMed ID: 25871522
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway.
Wang CH; Shyu RY; Wu CC; Tsai TC; Wang LK; Chen ML; Jiang SY; Tsai FM
J Biomed Sci; 2014 May; 21(1):36. PubMed ID: 24884338
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type.
Uyama T; Morishita J; Jin XH; Okamoto Y; Tsuboi K; Ueda N
J Lipid Res; 2009 Apr; 50(4):685-93. PubMed ID: 19047760
[TBL] [Abstract][Full Text] [Related]
5. H-rev107 Regulates Cytochrome P450 Reductase Activity and Increases Lipid Accumulation.
Tsai FM; Chen ML; Wang LK; Lee MC
PLoS One; 2015; 10(9):e0138586. PubMed ID: 26381418
[TBL] [Abstract][Full Text] [Related]
6. H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling.
Nazarenko I; Kristiansen G; Fonfara S; Guenther R; Gieseler C; Kemmner W; Schafer R; Petersen I; Sers C
Am J Pathol; 2006 Oct; 169(4):1427-39. PubMed ID: 17003497
[TBL] [Abstract][Full Text] [Related]
7. Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts.
Hajnal A; Klemenz R; Schäfer R
Oncogene; 1994 Feb; 9(2):479-90. PubMed ID: 8290259
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the N-terminal catalytic domain of human H-REV107--a novel circular permutated NlpC/P60 domain.
Ren X; Lin J; Jin C; Xia B
FEBS Lett; 2010 Oct; 584(19):4222-6. PubMed ID: 20837014
[TBL] [Abstract][Full Text] [Related]
9. Regulation of peroxisomal lipid metabolism by catalytic activity of tumor suppressor H-rev107.
Uyama T; Ichi I; Kono N; Inoue A; Tsuboi K; Jin XH; Araki N; Aoki J; Arai H; Ueda N
J Biol Chem; 2012 Jan; 287(4):2706-18. PubMed ID: 22134920
[TBL] [Abstract][Full Text] [Related]
10. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.
Sers C; Husmann K; Nazarenko I; Reich S; Wiechen K; Zhumabayeva B; Adhikari P; Schröder K; Gontarewicz A; Schäfer R
Oncogene; 2002 Apr; 21(18):2829-39. PubMed ID: 11973642
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
[TBL] [Abstract][Full Text] [Related]
12. Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors.
Sers C; Emmenegger U; Husmann K; Bucher K; Andres AC; Schäfer R
J Cell Biol; 1997 Feb; 136(4):935-44. PubMed ID: 9049257
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12.
Husmann K; Sers C; Fietze E; Mincheva A; Lichter P; Schäfer R
Oncogene; 1998 Sep; 17(10):1305-12. PubMed ID: 9771974
[TBL] [Abstract][Full Text] [Related]
14. H-rev107 regulates prostaglandin D2 synthase-mediated suppression of cellular invasion in testicular cancer cells.
Shyu RY; Wu CC; Wang CH; Tsai TC; Wang LK; Chen ML; Jiang SY; Tsai FM
J Biomed Sci; 2013 May; 20(1):30. PubMed ID: 23687991
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Phospholipase A/Acyltransferase-3 with Pex19p: A POSSIBLE INVOLVEMENT IN THE DOWN-REGULATION OF PEROXISOMES.
Uyama T; Kawai K; Kono N; Watanabe M; Tsuboi K; Inoue T; Araki N; Arai H; Ueda N
J Biol Chem; 2015 Jul; 290(28):17520-34. PubMed ID: 26018079
[TBL] [Abstract][Full Text] [Related]
16. The RAS-Binding Domain of Human BRAF Protein Serine/Threonine Kinase Exhibits Allosteric Conformational Changes upon Binding HRAS.
Aramini JM; Vorobiev SM; Tuberty LM; Janjua H; Campbell ET; Seetharaman J; Su M; Huang YJ; Acton TB; Xiao R; Tong L; Montelione GT
Structure; 2015 Aug; 23(8):1382-1393. PubMed ID: 26165597
[TBL] [Abstract][Full Text] [Related]
17. The Structure of the ZMYND8/Drebrin Complex Suggests a Cytoplasmic Sequestering Mechanism of ZMYND8 by Drebrin.
Yao N; Li J; Liu H; Wan J; Liu W; Zhang M
Structure; 2017 Nov; 25(11):1657-1666.e3. PubMed ID: 28966017
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain.
Malki I; Cantrelle FX; Sottejeau Y; Lippens G; Lambert JC; Landrieu I
FEBS J; 2017 Oct; 284(19):3218-3229. PubMed ID: 28755476
[TBL] [Abstract][Full Text] [Related]
19. K-Ras
Feng H; Zhang Y; Bos PH; Chambers JM; Dupont MM; Stockwell BR
Biochemistry; 2019 May; 58(21):2542-2554. PubMed ID: 31042025
[TBL] [Abstract][Full Text] [Related]
20. A H-REV107 Peptide Inhibits Tumor Growth and Interacts Directly with Oncogenic KRAS Mutants.
Han CW; Jeong MS; Ha SC; Jang SB
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
